Differences in clinical outcomes in keratitis due to fungus and bacteria.
N Venkatesh
NV
Prajna
Muthiah
M
Srinivasan
Prajna
P
Lalitha
Tiruvengada
T
Krishnan
Revathi
R
Rajaraman
Meenakshi
M
Ravindran
Jeena
J
Mascarenhas
Catherine E
CE
Oldenburg
Kathryn J
KJ
Ray
Stephen D
SD
McLeod
Nisha R
NR
Acharya
Thomas M
TM
Lietman
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D057112:Corneal Perforation / Q000175:diagnosis; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology; D005658:Fungi / Q000302:isolation & purification; D006801:Humans; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents